METHODS TO PRODUCE ROD-DERIVED CONE VIABILITY FACTOR (RDCVF)

COMPOSITIONS AND METHODS USING REELIN IN ALZHEIMER'S DISEASE

Biomarkers for the early detection of breast cancer

MODULATION OF PROTEIN DEGRADATION

MINIGENE THERAPY

COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE

METHODS AND COMPOSITIONS TO MODULATE T CELL METABOLISM, FUNCTION, AND FATE

LIPID NANOPARTICLE-BASED DRUG DELIVERY SYSTEM USING RECOMBINANT PROTAMINE AND METHOD FOR PREPARING SAME

TRANSGENIC ANIMALS AND RECOMBINANT HOST CELLS COMPRISING SPECIFIC GENE VARIANTS AND METHODS OF CREATING SAME

ENGINEERED MUSCLE TARGETING COMPOSITIONS

FISH ALLERGY ANTIGEN

KIF MODULATOR COMPOUNDS AND METHODS OF USE

Validation of Neoepitope Presentation

RECOMBINANT SPIRULINA EXPRESSING SCAFFOLDS AND METHODS OF UTILIZING THE SAME

STING-TARGETING GENE THERAPY

Polyamine Reporters

NON-HUMAN ANIMALS COMPRISING A MODIFIED TRANSFERRIN RECEPTOR LOCUS

REGULATION OF RAN TRANSLATION BY PKR AND EIF2A-P PATHWAYS

GENE THERAPY TREATMENT

USE OF A SMALL NATIVE PEPTIDE ACTIVATOR OF SERCA PUMP FOR TREATMENT OF HEART FAILURE AND OTHER DISORDERS CHARACTERIZED BY CYTOSOLIC CALCIUM OVERLOAD

RAS BIOSENSORS

ENGINEERED MUSCLE TARGETING COMPOSITIONS

REDUCING-AGENT-FREE DNA POLYMERASE WITH REDUCED ARTIFACT FORMATION

ADENO-ASSOCIATED VIRUS DELIVERY OF CLN3 POLYNUCLEOTIDE

ECTODERMAL MESENCHYMAL STEM CELLS AND METHOD FOR PRODUCING SAME

OPTIMIZED TARGET-SPECIFIC GENE EXPRESSION REGULATION TECHNOLOGY BASED ON THE ULTRA-MINIATURIZED OMEGA SYSTEM

MATERIALS AND METHODS FOR TREATING FRIEDREICH'S ATAXIA

GASTROINTESTINAL TRACT STABILIZED PROTEIN DELIVERY USING DISULFIDE TES SYSTEM

RECOMBINANT ADENO-ASSOCIATED VIRUS FOR TREATMENT OF GRN-ASSOCIATED ADULT-ONSET NEURODEGENERATION

ANTI-HOG TCN1 MONOCLONAL ANTIBODIES AND METHODS OF PRODUCTION AND USE THEREOF

VIRAL VECTOR

TREATMENTS FOR CELLULAR REJUVENATION

NECTIN-4 MINIPROTEIN CONJUGATES

VACCINE PLATFORM

POLYPEPTIDES COMPRISING HISTONE CODE READER DOMAINS AND USES THEREOF

A HYPOIMMUNOGENIC CELL AND METHODS OF GENERATION THEREOF

Treatment for Reducing or Preventing Tissue Fibrosis

CONSTRUCTION OF ENGINEERED EXTRACELLULAR VESICLE AND USE THEREOF

PHARMACEUTICAL COMPOSITION, COMPRISING RECOMBINANT STABILIZED GALECTIN 9 PROTEIN, FOR PREVENTION OR TREATMENT OF RHEUMATOID ARTHRITIS AND BONE DISEASE

NOVEL NMU RECEPTOR 2 AGONISTS

METHODS AND COMPOSITIONS FOR PROMOTING OPC DIFFERENTIATION AND REMYELINATION USING RECEPTOR ASSOCIATED PROTEIN (RAP)

ENGINEERED TUBEROUS SCLEROSIS COMPLEX 2 POLYPEPTIDES

TARGETING ANABOLIC DRUGS FOR ACCELERATED FRACTURE REPAIR

MODULAR RNA DELIVERY PLATFORMS AND METHODS OF THEIR USE

INDUCIBLE CASPASES AND METHODS FOR USE

LINC COMPLEX INHIBITING POLYPEPTIDES

METHODS OF TREATING NON-SYNDROMIC SENSORINEURAL HEARING LOSS

ENHANCING EFFECTOR CELL DURABILITY AND EFFICACY IN ADOPTIVE CELL THERAPIES

ANNEXIN A1-DERIVED POLYPEPTIDE ANALOGUES

Unconstrained Genome Targeting with near-PAMless Engineered CRISPR-Cas9 Variants

MANIPULATION OF EIF3 TO MODULATE REPEAT ASSOCIATED NON-ATG (RAN) TRANSLATION

SYNAPSE SURGERY TOOLS AND ASSOCIATED METHODS FOR NEURAL CIRCUIT-SPECIFIC SYNAPSE ABLATION AND MODIFICATION

HMGB1 PROTEIN DERIVATIVES FOR THE REMOVAL OF BIOFILMS

GP96 AND USE THEREOF IN TREATING AMYOTROPHIC LATERAL SCLEROSIS

COILED-COIL PEPTIDES FOR FORCE-DEPENDENT APPLICATIONS

THERAPEUTIC AND/OR PROPHYLACTIC ANTI-VIRAL AGENT

NOVEL ZINC FINGER FUSION PROTEINS FOR NUCLEOBASE EDITING

VECTOR-BASED GENE THERAPY FOR ELONGATOR ACETYLTRANSFERASE COMPLEX SUBUNIT 1 (ELP1)

PROTEASE-RESPONSIVE SURFACE-POTENTIAL-TUNABLE PEPTIDE CONSTRUCTS FOR SELECTIVE IMAGING AND ACCURATE INHIBITOR SCREENING

ERYTHROID-SPECIFIC PROMOTER AND METHOD OF USE THEREOF

LENTIVIRAL VECTORS USEFUL FOR THE TREATMENT OF DISEASE

Modification and Compositions of Human Secretoglobin Proteins

GENE DELIVERY SYSTEM AND APPLICATION THEREOF IN PREPARATION OF DRUGS FOR TREATMENT OF TUMORS

SELF-ACTIVATING FÖRSTER RESONANCE ENERGY TRANSFER (saFRET) BIOSENSORS AND METHODS FOR MAKING AND USING THEM

EXTRACELLULAR VESICLES COMPRISING SMALL INTERFERING RNA

ISOFORM NELL-1 PEPTIDE

GENE THERAPY FOR BVES-RELATED DISORDERS

NOVEL PEPTIDE MIMICS AND THEIR USE

NOVEL FUSION MOLECULES AND USES THEREOF

ZINC FINGER DOMAIN, AND METHOD FOR RECOVERING COBALT IONS BY USING SAME

COMPOSITIONS AND METHODS FOR MULTIPLEX PROJECTION TRACING AND MULTI-MODAL PROFILING OF PROJECTION NEURONS USING PROJECTION-TAGs

TRANSFERRIN RECEPTOR-BINDING DOMAINS AND PROTEINS COMPRISING THE SAME

FUSION MOLECULES AND USES THEREOF

NOVEL FUSION MOLECULES AND USES THEREOF

POLYPEPTIDES BINDING TO HUMAN COMPLEMENT C5

MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF

POLYPEPTIDES AND METHODS OF USE

COMPOSITIONS AND METHODS FOR INDUCING AN IMMUNE RESPONSE AGAINST EPSTEIN-BARR VIRUS

Inhibitors of atp synthase - cosmetic and therapeutic uses

D-DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF

Cancer Vaccines and Methods of Treatment Using The Same

COMPOSITIONS AND METHODS FOR TREATING NON-AGE-ASSOCIATED HEARING IMPAIRMENT IN A HUMAN SUBJECT

INTERFERON REGULATORY FACTOR 5 INHIBITORS AND USES THEREOF

TREATMENTS FOR AGE-RELATED CELLULAR DYSFUNCTION

COMPOSITIONS AND METHODS FOR TREATING NON-AGE-ASSOCIATED HEARING IMPAIRMENT IN A HUMAN SUBJECT

cGMP EXOSOME LOADED THERAPEUTICS FOR TREATING SICKLE CELL DISEASE

COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES

USE OF RS1 GENE IN PREPARING THERAPEUTIC AGENT FOR XLRS, AND THERAPEUTIC AGENT

DUAL RECOMBINANT AAV8 VECTOR SYSTEM ENCODING ISOFORM 5 OF OTOFERLIN AND USES THEREOF

ADENOVIRAL CHIMERIC TDP-43 PROTEINS

ALTERNATIVE SPLICING ENHANCER MOLECULES

METHODS AND COMPOSITIONS FOR PROTEIN SEQUENCING

Lipocalin 10 and its Truncated Protein as Therapeutic Agents for Inflammation-Induced Organ Dysfunction

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING METABOLIC DISORDERS

Compositions and Methods for the Treatment of Congenital Ichthyoses

Novel Anti-Bacterial Peptides Derived From Differentiating Stem Cells

GENETICALLY ENGINEERED INNATE LYMPHOID CELLS FOR ENHANCING LIFESPAN AND/OR TREATING CANCERS

ANTIBACTERIAL AND MINERALIZING COMPOSITIONS AND METHODS OF USE THEREOF

TARGETED AUGMENTATION OF NUCLEAR GENE OUTPUT

USE OF HUMAN UMBILICAL CORD MESENCHYMAL STEM CELL-DERIVED EXOSOMES (hUC-MSC-ES)

Method for Preparing Stem Cells Having Improved Engraftment Capability

METHOD FOR PREVENTING OR TREATING CANCER BY BLOCKING EXCESSIVE PRODUCTION OF PHOSPHORYLATED VIMENTIN

ALLERGY ANTIGEN AND EPITOPE THEREOF

Compositions and Method of Use for Hair Straightening and Shaping

VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION

ICAM-1 TARGETED FUSION ENZYMES

TARGETED INTRACELLULAR DELIVERY OF LARGE NUCLEIC ACIDS

LENTIVIRAL VECTOR

VECTORS, GENETICALLY MODIFIED CELLS, AND GENETICALLY MODIFIED NON-HUMAN ANIMALS COMPRISING THE SAME

RIBOSOMAL ENGAGEMENT POTENCY ASSAY

CAPSIDS FOR PLAKOPHILLIN-2 GENE THERAPY

COMBINATION THERAPY WITH ADP-RIBOSE BINDING PEPTIDE AND ADP-RIBOSE FOR PREVENTION OR TREATMENT OF CANCER

CHIMERIC EFFEROCYTIC RECEPTORS IMPROVE APOPTOTIC CELL CLEARANCE AND ALLEVIATE INFLAMMATION

COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATION

COMPOSITIONS AND METHODS RELATED TO THE METHYLATION OF HISTONE H1.0 PROTEIN

LIVE CELL IMAGING PLATFORM FOR CONDENSATES

MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF

FUSION PROTEINS AND METHODS THEREOF

MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF

FUNCTIONAL POROSOME MANIPULATION

MHC IB-MEDIATED MYELIN-SPECIFIC IMMUNOSUPPRESSION AS A NOVEL TREATMENT FOR MULTIPLE SCLEROSIS AND MOG ANTIBODY DISEASE

METHODS AND COMPOSITIONS FOR DISRUPTING TAU AGGREGATES USING POLYSERINE REPEAT SEQUENCES TARGETING EXOGENOUS PROTEINS

METHOD TO STIMULATE REGENERATION OF RETINAL GANGLION CELLS

Method of Treating Osteoarthritis

ACTIVIN RECEPTOR TYPE IIB VARIANTS AND METHODS OF USE THEREOF

CURCUMIN-PEPTIDE CONJUGATES AND FORMULATIONS THEREOF

Intrathecal Delivery of Recombinant Adeno-Associated Virus 9

METHODS FOR USING EXOSOMES TO MONITOR TRANSPLANTED ORGAN STATUS

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

RNA TARGETING COMPOSITIONS AND METHODS OF USE THEREOF

PROGRAMMABLE IMMUNOCYTE RECEPTOR COMPLEX SYSTEM

METHODS OF IDENTIFYING PROXIMITY EFFECTOR POLYPETIDES AND METHODS OF USE THEREOF

MATERIALS AND METHODS FOR THE TREATMENT OF EIF2B5 MUTATIONS AND DISEASES RESULTING THEREFROM

ENGINEERED RECOMBINANT PROTEIN-BINDING DOMAINS AS DETECTION REAGENTS

TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS

PEPTIDES TARGETING THE INTERACTION BETWEEN KINDLIN-1 AND Beta-INTEGRIN

THERAPEUTIC mRNA

PEPTIDIC INHIBITORS OF AMYLOID SELF- AND CROSS-ASSEMBLY

Medical application and pharmaceutical composition of UbV.E4B protein

NUCLEOPHOSMIN PROTEIN (NPM) MUTANTS, CORRESPONDING GENE SEQUENCES AND USES THEREOF

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

TREATMENT FOR NUCLEOTIDE REPEAT EXPANSION DISEASE

D-DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF

PEPTIDE ANALOGS

De Novo Designed Cortisol Biosensor

METHOD OF DISRUPTING MEMORY AND LIPOPEPTIDE FOR USE IN SUCH METHOD

GPR17 PROMOTER-BASED TARGETING AND TRANSDUCTION OF GLIAL PROGENITOR CELLS

STABILISING THE HUMAN SPINDLE BY KIFC1/HSET

METHODS TO PRODUCE RECOMBINANT CUTIBACTERIUM ACNES AND USES THEREOF

COMPOSITIONS AND METHODS OF TREATING TISSUE DAMAGE

COMPOSITIONS AND MATERIALS FOR REGENERATION OF SKELETAL MUSCLE

COMPOSITIONS AND METHODS FOR TARGETING NUCLEAR IMPORT SHUTTLES AND TREATING INFLAMMATORY DISORDERS

ALLOGRAFT TOLERANCE WITHOUT THE NEED FOR SYSTEMIC IMMUNE SUPPRESSION

MRNA REGULON THERAPY FOR THE TREATMENT OF HAPLOINSUFFICIENCY DISORDERS

COMPOSITIONS FOR AND METHOD OF EFFECTING TUMOR CELL DEATH

DNA VACCINE AGAINST LEISHMANIASIS

TRANSGENIC MOUSE

PROTEIN DEGRADER

METHODS AND COMPOSITIONS FOR PROTEIN SEQUENCING

FUSION PROTEIN, AND PREPARATION METHOD THEREFOR AND USE THEREOF

COMPOSITIONS AND METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING OTOFERLIN DUAL VECTOR SYSTEMS

ATF5 Peptide Variants and Uses Thereof

COMPOSITIONS AND METHODS FOR INCREASING PLANT GROWTH AND IMPROVING MULTIPLE YIELD-RELATED TRAITS

OPTIMIZED PROTEIN FUSIONS AND LINKERS

SMART SINGLE-DOMAIN INTRABODIES WITH PRECISION SWITCHES FOR BIOMEDICAL APPLICATIONS

REGULATING MICROTUBULE DYNAMICS AS A THERAPEUTIC TARGET FOR NERVE REPAIR

Nucleic Acids, Methods and Kits for the Diagnosis of DYT6 Primary Torsion Dystonia

DESIGNER MEMBRANELESS ORGANELLES SEQUESTER NATIVE FACTORS FOR CONTROL OF CELL BEHAVIOR

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING FIBROSIS

WHEY PROTEIN MICELLES AGAINST MUSCLE ATROPHY AND SARCOPENIA

METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE

VECTORS AND COMPOSITIONS FOR GENE AUGMENTATION OF CRUMBS COMPLEX HOMOLOGUE 1 (CRB1) MUTATIONS

TRIGGER NUCLEIC ACIDS AND RNA-BINDING PROTEINS FOR UPREGULATING GENE EXPRESSION

BINDING PROTEINS SPECIFIC FOR CD32A

AAV TRANSFER PLASMIDS

COMPOSITIONS FOR MODULATING AN XBP1 PATHWAY IN A KERATINOCYTE AND METHODS OF USE

Antigens Derived from Citrullinated 14-3-3 and Uses Thereof in the Diagnosis of Rheumatoid Arthritis

H3.3 CTL PEPTIDES AND USES THEREOF

CHIMERIC POXVIRUS COMPOSITIONS AND USES THEREOF

METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING A DISEASE OR DISORDER ASSOCIATED WITH ABNORMAL LEVEL AND/OR ACTIVITY OF THE IFP35 FAMILY OF PROTEINS

MOLECULES FOR ORGANELLE-SPECIFIC PROTEIN DELIVERY

ESCHERICHIA COLI ENGINEERING STRAIN FOR FUSION EXPRESSION OF TAU-4R PROTEIN

FUSED CYCLOOCTYNE COMPOUNDS AND THEIR USE IN METAL-FREE CLICK REACTIONS

NANOPARTICLES COMPRISING FUSION PROTEIN OF SINGLE-CHAIN VARIABLE FRAGMENT AND FERRITIN, AND USE THEREOF

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY-RELATED PROTEINS AND PEPTIDES

PEPTIDES, HYDROGEL COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS TO INNER EAR

COMPOSITIONS AND METHODS FOR DELIVERING CARGO TO A TARGET CELL

METHODS AND COMPOSITIONS FOR DIAGNOSING BRAIN INJURY OR NEURODEGENERATION

MEANS AND METHOD FOR PREPARING VIRAL VECTORS AND USES OF SAME

COMPOSITIONS AND METHODS FOR TREATMENT OF CHRONIC LUNG DISEASES

METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING A DISEASE OR DISORDER ASSOCIATED WITH ABNORMAL LEVEL AND/OR ACTIVITY OF THE IFP35 FAMILY OF PROTEINS

PROTEINS WITH CARDIOPROTECTIVE ACTIVITY

ENGINEERED MUSCLE TARGETING COMPOSITIONS

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

EXTENDED RECOMBINANT POLYPEPTIDES AND COMPOSITIONS COMPRISING SAME

OPTIMIZED EXPRESSION CASSETTES FOR GENE THERAPY

GENE THERAPY FOR LAMIN A-ASSOCIATED DEFICIENCIES

ENGINEERED IMMUNE CELL

VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION

DESIGNED REPEAT DOMAINS WITH DUAL BINDING SPECIFICITY AND THEIR USE

METHODS AND COMPOSITIONS RELATING TO HUMANIZED STATHMIN2 MOUSE MODEL WITH DISRUPTED TDP-43 BINDING SITES

MUTANT MYOCILIN DISEASE MODEL AND USES THEREOF

COMPOSITIONS FOR PREVENTING OR TREATING INFLUENZA INFECTIONS

STEREOSELECTIVE COVALENT LIGANDS FOR ONCOGENIC AND IMMUNOLOGICAL PROTEINS

VHH POLYPEPTIDES THAT BIND TO CLOSTRIDIUM DIFFICILE TOXIN B AND METHODS OF USE THEREOF

PNEUMOCOCCAL FUSION PROTEIN VACCINES

SORTING WITH COUNTER SELECTION USING SEQUENCE SIMILAR PEPTIDES

A Composition and A Method of Rejuvenating DNA and Preventing DNA Damage

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE

NON-HUMAN ANIMALS COMPRISING A MODIFIED CACNG1 LOCUS

BIOCATALYSTS FOR EZETIMIBE SYNTHESIS

MODIFIED MULTABODY CONSTRUCTS, COMPOSITIONS, AND METHODS TARGETING SARS-COV-2

HUMANIZED ANTI-PACAP ANTIBODIES AND USES THEREOF

METHOD AND USE OF PROTEIN-RICH MIXTURE

INTRACELLULAR GLYCAN PROXIMITY LABELING METHODS AND APPLICATIONS THEREOF

MATERIALS AND METHODS FOR SLC6A1 GENE THERAPY

INHIBITORS OF T-CELL ACTIVATION

COMPOSITIONS AND METHODS FOR OPTOGENIC INDUCTION OF POLYPEPTIDE AGGREGATION

NPY2 RECEPTOR AGONISTS

Compositions and methods for treating non-age-associated hearing impairment in a human subject

MUTANT BRD4 POLYPEPTIDES AND METHODS OF USE THEREOF

RECOMBINANT FUSION ANTIBODY, AND ANTIBODY-DRUG CONJUGATE AND USE THEREOF

Methods and Compositions for Protein Synthesis and Secretion

AAV-MEDIATED THERAPIES FOR VISION LOSS ASSOCIATED WITH FRIEDREICH’S ATAXIA

PYROPTOSIS-TRIGGERING LIPID NANOPARTICLE

GENE CONSTRUCT FOR EXPRESSING MRNA

FC FUSION MOLECULES AND USES THEREOF

UFMYLATION INHIBITION TO TARGET TAUOPATHY IN HUMAN NEURONS

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS

METHODS AND COMPOSITIONS FOR TREATING CANCER

FOOD COMPOSITIONS COMPRISING RECOMBINANT CELLS COMPRISING TRANSCOBALAMIN

NEURODEGENERATIVE AND AMYOTROPHIC MODEL ANIMAL

STEREOCILIN PROMOTERS AND USES THEREOF

EFFECTIVE GENERATION OF TUMOR-TARGETED T CELLS DERIVED FROM PLURIPOTENT STEM CELLS

OPTIMIZED MULTABODY CONSTRUCTS, COMPOSITIONS, AND METHODS

COMPOSITIONS AND METHODS FOR THE TREATMENT OF P53-MEDIATED CANCERS

MAMMALIAN CARDIAC REGENERATION

C3-CARBON LINKED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION

METHODS OF TREATING CANCER HAVING AN ACTIVE WNT/BETA-CATENIN PATHWAY

NON-MEIOTIC ALLELE INTROGRESSION

MATERIALS AND METHODS FOR TREATING FRIEDREICH'S ATAXIA

COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS

COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS

Compositions and methods for treating non-age-associated hearing impairment in a human subject

FUSION PROTEINS OF NATURAL HUMAN PROTEIN FRAGMENTS TO CREATE ORDERLY MULTIMERIZED IMMUNOGLOBULIN Fc COMPOSITIONS

FRATAXIN GENE THERAPY

OPTIMIZED AP4M1 POLYNEUCLEOTIDES AND EXPRESSION CASSETTES AND THEIR USE

NOVEL PROTEIN HAVING METHANE OXIDATION ACTIVITY

COMPOSITIONS AND METHODS FOR DIAGNOSING AND/OR TREATING KIDNEY INJURY

PEPTIDE FOR INHIBITING CALCINEURIN AND USE THEREOF

Compositions and Methods of Use for Recombinant Human Secretoglobins

PROTEIN AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR PREVENTION OR TREATMENT OF CANCER

FUSION PROTEIN BETWEEN SHORT FORM ROD-DERIVED CONE VIABILITY FACTOR AND A HYDROPHILIC PEPTIDE

Activin Type 2 Receptor Binding Proteins and Methods of Making Them

COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS

COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS

COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS

COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS

PEPTIDE T14 FOR BRAAK STAGING

GENE THERAPY PRODUCTS FACILITATING BYSTANDER EFFECTS AND METHODS USING THE SAME

GRP78-BINDING ANTIBODIES AND USE THEREOF IN DETECTING OR NEUTRALIZING GRP78

SPYCATCHER ANALOGS AND USES THEREOF

NOVEL FUSION MOLECULES AND USES THEREOF

NANOSPHERES OF SEC14-LIKE PROTEINS AND COGNATE LIGANDS

Treatment Of Integrin-Related Disorders With Stapled Peptides

SYSTEM AND METHOD FOR INDUCING CLUSTERS OF GENE REGULATORY PROTEINS TARGETED TO SPECIFIC GENOMIC LOCI

MODIFIED REP-CAP PLASMIDS AND USES THEREOF

MASKED CHIMERIC ANTIGEN RECEPTOR SPECIFIC TO TYROSINE-PROTEIN KINASE LIKE 7 (PTK7) AND IMMUNE CELLS EXPRESSING SUCH

GENETICALLY MODIFIED PROBIOTICS FOR ORAL DELIVERY OF RENIN-ANGIOTENSIN RELATED THERAPEUTIC PROTEINS AND PEPTIDES

IMPROVED PROTEIN SORPTION AND FILTRATION APPARATUS

STAPLED INTRACELLULAR-TARGETING ANTIMICROBIAL PEPTIDES TO TREAT INFECTION

VECTOR ENCODING ROD-DERIVED CONE VIABILITY FACTOR AND HUMAN IGK SIGNAL SEQUENCE

CCDC7 CIRCULAR RNA ENCODED PROTEIN INHIBITS THE PROGRESSION OF PROSTATE CANCER BY UP-REGULATING FLRT3

HOMOLOGOUS DIMERIZATION PEPTIDES AND ANTIBODIES COMPRISING THE SAME

TROPONIN C (TNNC1) GENE THERAPY USING AAV VECTOR

ACTIVATABLE ANTIBODIES AND METHODS OF USE THEREOF

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE

ICAM-1 targeted fusion enzymes

APELIN POLYPEPTIDES

BIOMARKER PAIRS FOR PREDICTING PRETERM BIRTH

ADENO-ASSOCIATED VIRUS (AAV) SYSTEMS FOR TREATMENT OF PROGRANULIN ASSOCIATED NEURODEGENERATIVE DISEASES OR DISORDERS

PH20 polypeptide variants, formulations and uses thereof

MULTABODY CONSTRUCTS, COMPOSITIONS, AND METHODS

SEPARATION OF METAL IONS BY LIQUID-LIQUID EXTRACTION

SMALL MOBILE STEM CELLS (SMS) AND USES THEREOF

Methods and compositions for regenerating tissues

METHODS OF TREATING MITOCHONDRIAL DISORDERS

EXOSOME PACKAGING AND TARGETED AUTOPHAGY

NALCN Channel Protein and Modulators Thereof

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

TENASCIN-C AUTOANTIGENIC EPITOPES IN RHEUMATOID ARTHRITIS

MODULAR BINDING PROTEINS FOR EXTRACELLULAR VESICLES AND USES THEREOF

TCR-T CELL FOR KILLING TUMORS, AND PREPARATION METHOD THEREFOR AND USE THEREOF

FUSION PROTEINS AND METHODS THEREOF